Abstract | OBJECTIVES:
Peptide-based immune tolerance induction is considered an attractive treatment option for autoimmune diseases. The authors have developed a novel method that can enhance the induction of protective peptide-specific T-cell responses, using a rat arthritis model. The authors focused on the Toll-like receptor 9 ligand CpG, which was shown to stimulate regulatory T-cell proliferation when added to plasmacytoid dendritic cells (pDC) using in-vitro cultures. METHODS: The peptide used is a heat shock protein 60 epitope (p1) that elicits tolerogenic peptide-specific immune responses in human arthritis patients and was recently shown to have protective capacity as a bystander antigen in the rat adjuvant arthritis model. Rats were treated with three nasal doses of p1, CpG or a combination of p1 and CpG. Antigen-presenting cells were studied in nose-draining lymph nodes (mandibular lymph nodes; MLN) after nasal treatment, and T-cell responses were analysed in joint-draining lymph nodes after arthritis induction. RESULTS: Nasal co-administration of p1/CpG significantly augmented the arthritis-protective effect of p1, while CpG treatment alone did not. Co-treatment of p1/CpG increased both the number and activation status of pDC in draining MLN, which was accompanied by amplified p1-specific T-cell proliferation and interleukin (IL)-10 production. During early arthritis, p1-specific IL-10 production was identified at the site of inflammation. P1 and p1/CpG-treated rats showed a greater amount of CD4+FoxP3+ regulatory T cells in the joint-draining lymph nodes, which correlated with lower arthritis scores. CONCLUSIONS: These clinical and immunological data suggest the use of CpG as a potent adjuvant for mucosal peptide-specific immune therapy in arthritis.
|
Authors | Evelien Zonneveld-Huijssoon, Femke van Wijk, Sarah Roord, Eveline Delemarre, Jenny Meerding, Wilco de Jager, Mark Klein, Eyal Raz, Salvatore Albani, Wietse Kuis, Marianne Boes, Berent J Prakken |
Journal | Annals of the rheumatic diseases
(Ann Rheum Dis)
Vol. 71
Issue 10
Pg. 1706-15
(Oct 2012)
ISSN: 1468-2060 [Electronic] England |
PMID | 22562976
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adjuvants, Immunologic
- Chaperonin 60
- Epitopes, T-Lymphocyte
- Oligodeoxyribonucleotides
- Toll-Like Receptor 9
- Vaccines, Subunit
|
Topics |
- Adjuvants, Immunologic
(administration & dosage)
- Administration, Intranasal
- Animals
- Arthritis, Experimental
(immunology)
- Arthritis, Rheumatoid
(immunology)
- Chaperonin 60
(administration & dosage, immunology)
- Dendritic Cells
(immunology)
- Disease Models, Animal
- Epitopes, T-Lymphocyte
(immunology)
- Lymphocyte Activation
(immunology)
- Male
- Oligodeoxyribonucleotides
(administration & dosage, immunology)
- Rats
- Rats, Inbred Lew
- T-Lymphocytes, Regulatory
(immunology)
- Toll-Like Receptor 9
(agonists)
- Vaccines, Subunit
(administration & dosage, immunology)
|